DJIA 16,408.54 -16.31 -0.10%
NASDAQ 4,095.52 0.00 0.00%
S&P 500 1,864.85 2.54 0.14%
market minute promo


company name or ticker
Company Photos
(Click to zoom)

3 Stocks Reiterated As A Buy: BMY, CELG, V

Bristol-Myers Seeks Approval for HIV Combo Drug - Analyst Blog

Portola's Betrixaban Study Design Published - Analyst Blog

Noteworthy ETF Inflows: XLV, JNJ, AMGN, BMY

Hard-to-Cure Patients May Benefit from Merck's HCV Drug - Analyst Blog

Hard-to-Cure Patients May Benefit from Merck's HCV Drug - Analyst Blog

Positive Data on AbbVie's HCV Program - Analyst Blog

Positive Data on AbbVie's HCV Program - Analyst Blog

UPDATE: Bristol-Myers Squibb Submits NDA to US FDA for Fixed-Dose Combo Tablet for Atazanavir Sulfat

UPDATE: Bristol-Myers Squibb Submits NDA to US FDA for Fixed-Dose Combo Tablet for Atazanavir Sulfate with Cobicistate

3 Stocks Reiterated As A Buy: BMY, LOW, CSCO

Encouraging Data from Bristol-Myers - Analyst Blog

Market Hustle: Stock Futures Flat Ahead of JPMorgan, Wells Fargo Earnings

See More Articles...